ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

ViCentra Appoints Ian Wells as Chief Financial Officer and --> Accessibility: Skip TopNav ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board July 14, 2026 03:30 ET | Source: ViCentra ViCentra Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets discipline Tom West, who led Intersect ENT to its $1.1 billion acquisition by Medtronic and Nalu Medical to its $600 million acquisition by Boston Scientific, joins as an Independent Board Member Appointments build the financial and governance foundation for ViCentra’s next phase, following the recent scale-up of commercial manufacturing UTRECHT, The Netherlands, July 14, 2026 (GLOBE NEWSWIRE) -- ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, today announced the appointment of Ian Wells as Chief Financial Officer, effective June 19, 2026, and the addition of Thomas A. West, a veteran U.S. medical technology leader, to its Board of Directors as an Independent Director, effective July 1, 2026. Together, the appointments lay the financial and governance foundation for ViCentra to scale across Europe and enter the U.S. market following a year of sustained operational momentum. ViCentra closed a $98 million Series D financing, strengthened its leadership team, launched its smartphone-controlled Kaleido system with Diabeloop’s DBLG2 algorithm and Dexcom G7, and began commercial-scale production of Kaleido consumables through its manufacturing collaboration with Phillips Medisize, a Molex company. With manufacturing now at commercial scale and unit economics strengthening, ViCentra is adding the financial and strategic leadership to build on that foundation. “Ian and Tom’s appointments further strengthen the leadership team that we have assembled to support our next stage of growth. Following the successful scale-up of our commercial ma...